Plexus Corp.'s SEC filings document operating results, financial condition, governance matters and material corporate events for its complex product design, manufacturing and services business. Recent 8-K reports furnish quarterly and fiscal-year earnings releases and related financial information for the company's product lifecycle operations across regulated end markets.
The filings also record shareholder meeting results, including director elections, advisory executive compensation votes and auditor ratification, as well as officer transition and compensation-arrangement disclosures. These records describe formal governance actions, executive roles and recurring public-company reporting obligations for PLXS.
PLXS (Form 144): Notice of proposed sale of Common Stock by an affiliate broker-dealer. The filing lists 3,312 shares associated with restricted stock vesting under a registered plan dated 05/12/2025. The filing also discloses a recent sale of 3,815 shares on 05/06/2026 for $1,026,006.10.
Plexus Corp Regional President - APAC Victor (Pang Hau) Tan reported an open-market sale of 3,000 shares of Plexus Corp common stock. The shares were sold at a weighted average price of $271.2333 per share, with individual trades executed between $271.00 and $271.50 per share on May 11, 2026.
Following this transaction, Tan directly holds 10,457 Plexus Corp common shares. The filing notes that detailed trade-by-trade pricing and share information is available upon request from the reporting person.
Plexus Corp Senior Vice President and CFO David Westen Abuhl filed an initial ownership report showing his equity-based awards in the company. He reports 1,760 Performance Stock Units, each representing a right to receive one share of common stock if performance conditions are met.
He also reports 1,250 Restricted Stock Units granted on February 9, 2026 that vest three years from the grant date, and 7,500 Restricted Stock Units granted on September 15, 2025 that vest in three equal annual installments. The PSU award can pay out above target based on total shareholder return and economic return goals.
Plexus Corp EVP and Chief Legal & PAO & Secretary Angelo Michael Ninivaggi Jr reported open-market sales of 5,568 shares of Plexus common stock on May 7–8, 2026. The trades were executed at weighted average prices in multiple transactions, with individual trade prices ranging from about $262.00 to $266.20 per share. Following these sales, he continues to hold 16,266 shares of Plexus common stock directly.
PLXS filing on Form 144 lists a proposed sale of 3,000 common shares for disposition on 05/11/2026 on NASDAQ, using Morgan Stanley Smith Barney LLC Executive Financial Services as the broker. The excerpt also lists Performance Stock Units dated 02/17/2026 (290), 11/12/2025 (2,332) and 02/11/2025 (378) shown under "Securities To Be Sold." The filing text shows "Not Applicable" in related fields and provides broker and quantity details only.
Plexus Corp Exec. VP & CFO Patrick John Jermain reported updated holdings of common stock. On May 6, 2026, a discretionary transaction under Rule 16b-3(f) involved 3,815 shares formerly held in the Plexus Corp. 401(k) Savings Plan at $268.9356 per share, leaving 17,534 shares held directly and none via the 401(k).
Form 144 filing reporting insider sale activity. The filing lists securities to be sold including 1,521 and 1,749 Performance Stock Units with grant dates 02/16/2022 and 02/11/2025. It discloses a sale by Angelo M. Ninivaggi of 2,298 common shares on 05/07/2026 for $604,340.22.
Filer submitted a Form 144 notice proposing the sale of Common Stock of PLXS. The filing lists an intermediary Fidelity Investments at 245 Summer St, Boston and shows a Nasdaq listing with a filing date of 05/08/2026. The excerpt also lists prior stock awards to Michael V. Schrock dated 01/29/2025, 01/30/2024, 01/31/2023 and 01/25/2022 with respective award counts.
Form 144 filing for PLXS: notice of proposed sale of common stock. The filing lists transactions tied to restricted stock vesting under a registered plan and performance stock units, showing 1,771 and 527 shares respectively with grant/vesting dates 01/21/2022 and 02/16/2022. The broker/custodian is Morgan Stanley Smith Barney LLC, and the filing date shown is 05/07/2026.
Plexus Corp. delivered strong growth for the quarter ended April 4, 2026. Net sales rose to $1.16 billion from $980.2 million, an 18.7% increase, driven by higher demand across AMER, APAC and EMEA regions and all three market sectors.
Net income increased to $49.8 million from $39.1 million, with diluted EPS up to $1.82 from $1.41. Gross margin edged up to 10.2% and operating margin to 5.3%, helped by higher volumes and favorable mix despite higher fixed and compensation costs.
Cash generation weakened as operating cash flow fell to $13.1 million from $90.3 million, largely due to higher inventories and other working capital uses, resulting in free cash flow of negative $34.6 million. The company ended with $303.2 million in cash and $234.1 million of debt and spent $43.0 million repurchasing 262,092 shares, with $42.0 million remaining under its current buyback authorization.